Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stephanie Sampson
Risperidone Versus Placebo for Schizophrenia
Cochrane Database of Systematic Reviews
Chlorpromazine Versus Atypical Antipsychotic Drugs for Schizophrenia
Related publications
Risperidone for Individuals With Refractory Schizophrenia
Clinical Medicine Insights: Therapeutics
Medicine
Pharmacology
Pharmaceutical Science
Short Term Effectiveness of Haloperidol Versus Risperidone in First-Episode Schizophrenia
Proceedings of Singapore Healthcare
Medicine
A Cost Utility Analysis of CYP2D6 Pharmacogenetic Guided Dosing Versus Standard Dosing of Risperidone for Treatment of Schizophrenia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparison of Somnolence Associated With Asenapine, Olanzapine, Risperidone, and Haloperidol Relative to Placebo in Patients With Schizophrenia or Bipolar Disorder
Neuropsychiatric Disease and Treatment
Psychiatry
Mental Health
Biological Psychiatry
Cost Effectiveness of Paliperidone Palmitate Versus Risperidone Long-Acting Injectable, Quetiapine and Olanzapine for the Treatment of Patients With Schizophrenia in Colombia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effects of Continuing Oral Risperidone vs. Switching From Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
Frontiers in Psychiatry
Psychiatry
Mental Health
Clinical Utility of the Risperidone Formulations in the Management of Schizophrenia
Neuropsychiatric Disease and Treatment
Psychiatry
Mental Health
Biological Psychiatry
Risperidone vs Olanzapine in Treatment of Schizophrenia: A Double Blind Clinical Trial
MOJ Addiction Medicine & Therapy
